NCT05962606 2026-03-18Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.Aptarion Biotech AGPhase 2 Completed150 enrolled
NCT04358406 2023-11-28Rhu-pGSN for Severe Covid-19 PneumoniaBioAegis Therapeutics Inc.Phase 2 Completed64 enrolled 17 charts